Zenith Financial Statements From 2010 to 2025
| ZHCLF Stock | USD 0.0001 0.00 0.00% |
Check Zenith Capital financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zenith Capital's main balance sheet or income statement drivers, such as , as well as many indicators such as . Zenith financial statements analysis is a perfect complement when working with Zenith Capital Valuation or Volatility modules.
Zenith |
Zenith Capital Corp Company Total Debt Analysis
Zenith Capital's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Zenith Capital Total Debt | 3.94 M |
Most of Zenith Capital's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zenith Capital Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Zenith Capital Corp has a Total Debt of 3.94 M. This is 99.86% lower than that of the Healthcare sector and 98.79% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.93% higher than that of the company.
Zenith Capital Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zenith Capital's current stock value. Our valuation model uses many indicators to compare Zenith Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zenith Capital competition to find correlations between indicators driving Zenith Capital's intrinsic value. More Info.Zenith Capital Corp is rated first in return on asset category among its peers. It is rated first in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zenith Capital's earnings, one of the primary drivers of an investment's value.About Zenith Capital Financial Statements
Zenith Capital stakeholders use historical fundamental indicators, such as Zenith Capital's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zenith Capital investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zenith Capital's assets and liabilities are reflected in the revenues and expenses on Zenith Capital's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zenith Capital Corp. Please read more on our technical analysis and fundamental analysis pages.
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company was incorporated in 2013 and is headquartered in Calgary, Canada. Zenith Cap operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Zenith Pink Sheet
Zenith Capital financial ratios help investors to determine whether Zenith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenith with respect to the benefits of owning Zenith Capital security.